🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/02/2006 50,00 50,30 46,70 49,50 -1,00% 7,20% 5.600
02/02/2006 52,00 52,00 48,60 50,00 -2,15% 6,54% 4.240
01/02/2006 51,00 52,00 50,20 51,10 +0,20% 3,53% 12.060
31/01/2006 49,40 51,51 49,20 51,00 +4,08% 4,68% 8.190
30/01/2006 50,50 50,50 47,50 49,00 -2,00% 5,94% 6.970
27/01/2006 50,70 50,80 48,00 50,00 -1,96% 5,52% 7.620
26/01/2006 50,70 51,50 50,00 51,00 +0,99% 2,96% 15.560
25/01/2006 49,00 52,00 47,70 50,50 +4,12% 8,78% 24.720
24/01/2006 45,10 49,00 44,10 48,50 +7,06% 10,86% 10.640
23/01/2006 47,50 47,50 44,70 45,30 -4,43% 5,89% 2.360
20/01/2006 47,60 48,50 45,00 47,40 -1,04% 7,35% 8.760
19/01/2006 48,20 48,20 46,00 47,90 +0,00% 4,56% 1.800
18/01/2006 45,00 48,50 45,00 47,90 +1,91% 7,78% 9.900
17/01/2006 47,30 47,50 45,00 47,00 +3,98% 5,29% 7.550
13/01/2006 47,00 47,40 43,22 45,20 -3,21% 8,89% 10.310
12/01/2006 46,50 47,40 44,90 46,70 +0,86% 5,38% 7.310
11/01/2006 42,20 47,40 41,00 46,30 +9,43% 15,17% 24.560
10/01/2006 44,00 44,00 41,70 42,31 -3,62% 5,23% 5.960
09/01/2006 41,60 44,10 40,00 43,90 +5,78% 9,86% 11.160
06/01/2006 41,10 41,80 39,90 41,50 +1,47% 4,62% 1.840
05/01/2006 40,00 43,90 39,80 40,90 -2,39% 10,25% 11.130
04/01/2006 40,50 42,40 39,50 41,90 +3,71% 7,16% 10.680
03/01/2006 44,40 44,50 39,10 40,40 -4,94% 12,16% 13.160
30/12/2005 50,00 50,00 39,00 42,50 -19,05% 22,00% 63.050
29/12/2005 33,00 53,50 33,00 52,50 +54,41% 62,12% 112.180
28/12/2005 32,70 34,00 32,00 34,00 +1,49% 6,12% 1.670
27/12/2005 32,50 33,90 32,50 33,50 +6,01% 4,31% 920
23/12/2005 31,30 33,00 30,90 31,60 +1,28% 6,71% 6.640
22/12/2005 33,40 34,90 30,70 31,20 -5,74% 12,57% 5.560
21/12/2005 35,00 35,00 33,10 33,10 -5,43% 5,43% 7.570